FDA Clearance Tracker · P030036-S139
Medtronic SelectSecure MRI SureScan Lead
Last checked: Nov 20, 2026Latest source record: Oct 3, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Oct 3, 2022
Approved
Time to decision
73 days
Received Jul 22, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030036-S139
- Device name
- Medtronic SelectSecure MRI SureScan Lead
- Applicant location
- Mounds View, MN
- Received
- Jul 22, 2022
- Decided
- Oct 3, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030036
Device type
- Device type
- Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval to expand the indications for use for the Medtronic SelectSecure MRI SureScan Lead Model 3830 to include pacing at the left bundle branch area as an alternative to right ventricular pacing.
Source documents
Other decisions for Medtronic Cardiac Rhythm Disease Management
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.